Cyclosporine News and Research

RSS
Cyclosporine is a drug used to help reduce the risk of rejection of organ and bone marrow transplants by the body. It is also used in clinical trials to make cancer cells more sensitive to anticancer drugs.
NeuroVive, HCL initiate CicloMulsion Phase III trial in myocardial infarction

NeuroVive, HCL initiate CicloMulsion Phase III trial in myocardial infarction

New results from largest multicenter clinical trial for heart transplant patients be released at ISHLT 2011

New results from largest multicenter clinical trial for heart transplant patients be released at ISHLT 2011

Merck enters definitive agreement to acquire Inspire

Merck enters definitive agreement to acquire Inspire

Smoking withdrawal after liver transplantation may protect against neoplasia development

Smoking withdrawal after liver transplantation may protect against neoplasia development

Smoking cessation after liver transplantation reduces incidence of malignancy

Smoking cessation after liver transplantation reduces incidence of malignancy

Isotechnika fourth quarter consolidated net loss increases to $2.42 million

Isotechnika fourth quarter consolidated net loss increases to $2.42 million

FDA approves change to prescribing information for Gilead Sciences' Letairis

FDA approves change to prescribing information for Gilead Sciences' Letairis

New therapeutic strategy improves superior renal function after kidney transplantation

New therapeutic strategy improves superior renal function after kidney transplantation

Inspire announces strategic corporate restructuring on its eye care business

Inspire announces strategic corporate restructuring on its eye care business

Inspire fourth quarter revenues increase 2% to $30.3 million

Inspire fourth quarter revenues increase 2% to $30.3 million

U.S. FDA clears QMS Everolimus Immunoassay to prevent rejection in kidney transplants

U.S. FDA clears QMS Everolimus Immunoassay to prevent rejection in kidney transplants

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment

Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment

FDA approves Novartis' Amturnide for treatment of high blood pressure

FDA approves Novartis' Amturnide for treatment of high blood pressure

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

Santen launches DIQUAS Ophthalmic Solution in Japan

Santen launches DIQUAS Ophthalmic Solution in Japan

No overall cancer risk in people who donate stem cells

No overall cancer risk in people who donate stem cells

New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease